Evidence map›Paper›PMID 32234468›Full record

ArticleInternational journal of antimicrobial agents2020

The epidemiology, diagnosis and treatment of COVID-19.

Pan Zhai, Yanbing Ding, Xia Wu, Junke Long, Yanjun Zhong, Yiming Li

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in International journal of antimicrobial agents, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 392 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
392citing papers in PubMed, 6 pooled it
24.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04860232 unknown statusnot on this mapstarted 2023, after this paper: background citation

Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospital.

TypeobservationalSponsorAssiut UniversityRan2023 to 2024Enrolled200ConditionsCovid19
NCT04860245 unknown statusnot on this map

Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospitals.

TypeobservationalSponsorAssiut UniversityRan2020 to 2021Enrolled200ConditionsCovid19
3 · Its place in the literature

Who cites it

392 citing papers in PubMed, 6 syntheses or guidelines pooled it, 1,046 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Trial
  8. Article
  9. In Vivo Preclinical Platforms to Study Coronavirus Infection.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

332 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Pan ZhaiDepartment of Neurology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430073, Hubei, China.
Yanbing DingDepartment of Neurology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430073, Hubei, China.
Xia WuDepartment of Respiratory Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430073, Hubei, China.
Junke LongDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Yanjun ZhongICU Center, The Second Xiangya Hospital, Central South University, Furong, Changsha, Hunan, 41001, China.
Yiming LiDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China. Electronic address: lym-fly@whu.edu.cn.
Hubei Provincial Hospital of Traditional Chinese Medicine · CNCentral South University · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 infection causes clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus. Human-to-human transmission via droplets, contaminated hands or surfaces has been described, with incubation times of 2-14 days. Early diagnosis, quarantine, and supportive treatments are essential to cure patients. This paper reviews the literature on all available information about the epidemiology, diagnosis, isolation and treatments of COVID-19. Treatments, including antiviral agents, chloroquine and hydroxychloroquine, corticosteroids, antibodies, convalescent plasma transfusion and vaccines, are discussed in this article. In addition, registered trials investigating treatment options for COVID-19 infection are listed.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralAntiviral AgentsClinical Laboratory TechniquesClinical Trials as TopicCOVID-19COVID-19 Drug TreatmentCOVID-19 TestingHumansSARS-CoV-2Antiviral AgentsClinical trialsCOVID-19DiagnosisIsolationPandemicRemdesivir

Identifiers

PMID32234468
PMCPMC7138178
OpenAlexW3013306614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.